Cargando…

Editorial: Mitochondrial therapy in neurological diseases

Detalles Bibliográficos
Autores principales:	Chang, Jui-Chih, Chen, Linyi, Chang, Chuang-Rung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376612/ https://www.ncbi.nlm.nih.gov/pubmed/35979147 http://dx.doi.org/10.3389/fnmol.2022.988792

Ejemplares similares

Mitochondrial Protein PGAM5 Emerges as a New Regulator in Neurological Diseases
por: Liang, Min-Zong, et al.
Publicado: (2021)

Mitochondrial protein dysfunction in pathogenesis of neurological diseases
por: Wang, Liang, et al.
Publicado: (2022)

Editorial: Ion Channels: Therapeutic Targets for Neurological Disease
por: Hou, Panpan, et al.
Publicado: (2021)

Editorial: Mitochondrial dysfunction as a target in neurodegenerative diseases
por: Perrone, Lorena
Publicado: (2023)

Editorial: Advances in understanding synaptic function and its dysfunction in neurological disorders
por: Mohammad, Farhan, et al.
Publicado: (2023)

Editorial: Cerebrospinal fluid dynamics and intracranial pressure elevation–Novel insights on molecular and physiological mechanisms, and implications for neurological disease
por: Patabendige, Adjanie, et al.
Publicado: (2022)

Editorial: Synaptic Failure and Circuits' Impairment—Cognitive and Neurological Disorders—Moving a Step Forward
por: Ahmed, Touqeer, et al.
Publicado: (2022)

Editorial: Brain cells' compensatory mechanisms in response to disease risk factors
por: Kim, Yong, et al.
Publicado: (2022)

Choroid plexus epithelium and its role in neurological diseases
por: Liu, Ruizhen, et al.
Publicado: (2022)

Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies
por: Ledri, Marco, et al.
Publicado: (2021)

Editorial: Ion channels and transporters in epilepsy: From genes and mechanisms to disease-targeted therapies
por: He, Hailan, et al.
Publicado: (2022)

m6A methylation: Critical roles in aging and neurological diseases
por: Fan, Yishu, et al.
Publicado: (2023)

Neuron-astrocyte omnidirectional signaling in neurological health and disease
por: Pathak, Dhruba, et al.
Publicado: (2023)

Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases
por: Lam, Simon, et al.
Publicado: (2022)

Editorial: “Role of Ribonucleoprotein Complexes in Neurodevelopment and in the Physiopathology of Neurological Diseases”
por: Gwizdek, Carole, et al.
Publicado: (2021)

Editorial: Retinal Changes in Neurological Diseases
por: Sharma, Samridhi, et al.
Publicado: (2022)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Editorial: Molecular mechanisms of neuropsychiatric diseases
por: Moreira-Rodrigues, Mónica, et al.
Publicado: (2022)

Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases
por: Soares, Milena B. P., et al.
Publicado: (2022)

Editorial: The protein kinase GSK3 in neurobiological functions and neuronal disorders
por: Plattner, Florian, et al.
Publicado: (2023)

Editorial: Current Insights Into LAMA2 Disease
por: Previtali, Stefano C., et al.
Publicado: (2021)

Editorial: The role of posttranslational modifications in polyglutamine diseases
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2023)

Editorial: Advanced (gene and cell) therapies for central nervous system applications
por: Mendonça, Liliana, et al.
Publicado: (2023)

Editorial: Animal models of multiple sclerosis: can they advance future therapies?
por: DeSilva, Tara Maria, et al.
Publicado: (2023)

Editorial: Gene therapy for the central and peripheral nervous system, volume II
por: Tosolini, Andrew P., et al.
Publicado: (2023)

Editorial: Cannabinoids as potential treatment for neurological diseases
por: Gómez-Cañas, María, et al.
Publicado: (2022)

Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions
por: Cavaleiro, Carla, et al.
Publicado: (2023)

Editorial: Small and mighty: Brain capillaries in health and disease
por: Bracko, Oliver, et al.
Publicado: (2022)

Editorial: Myelin in white mater function and related diseases
por: Tian, Zhen, et al.
Publicado: (2023)

Insights on therapeutic potential of clemastine in neurological disorders
por: Jiang, Sufang, et al.
Publicado: (2023)

Editorial: Model systems to study the mechanisms of neural development and disease
por: Sumru Bayin, N., et al.
Publicado: (2022)

Editorial: Molecular dynamics of cognitive-motor impairment in neurodegenerative diseases
por: Kumar, Dhiraj, et al.
Publicado: (2023)

Editorial: Global excellence in brain disease mechanisms: Asia & Australasia
por: Cunliffe, Grace, et al.
Publicado: (2023)

Editorial: Personalized care in neurological diseases
por: Fernandes, Júlio Belo, et al.
Publicado: (2023)

Glymphatic system: an emerging therapeutic approach for neurological disorders
por: Gao, Ying, et al.
Publicado: (2023)

Editorial: Bidirectional Communication Between Synapses and Nucleus in Brain Physiology and Disease
por: Parra-Damas, Arnaldo, et al.
Publicado: (2022)

Editorial: Developmental genes and molecular approaches: From embryo to human diseases
por: Spohr, Tania C. L. S., et al.
Publicado: (2022)

Editorial: The role of epigenetics in neuropsychiatric disorders
por: Shirinian, Margret, et al.
Publicado: (2022)

The role of Gadd45b in neurologic and neuropsychiatric disorders: An overview
por: Shen, Xiao-yue, et al.
Publicado: (2022)

Editorial: Protein Degradation, Aggregation, Membrane Trafficking and Exosomes in Neuronal Health and Disease
por: Campbell, Douglas S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2q3s4poq7nevq22g98d1cjnc5